The global pain and fever relief drugs market is anticipated to grow at a significant CAGR during the forecast period (2024-2031). The COVID-19 pandemic has initially created a high demand for these drugs, such as paracetamol. The majority of paracetamol API is exported from India and China. Due to the lockdown situation, most of the markets globally faced a shortage of paracetamol, leading to increased prices for paracetamol tablets online and in independent community pharmacies. Amid the COVID-19 situation, the governments of various authorities supported the local manufacturing of paracetamol. This will strengthen the local market players and competitiveness around the world.

Get Free Sample link @ https://www.omrglobal.com/request-sample/pain-and-fever-relief-drugs-market

The major factors that are responsible for the growth of the market include the rising prevalence of conditions such as headaches, and flu, among others and the increasing demand for pain management drugs. Paracetamol is widely used in the treatment of mild to moderate pain, including headache, menstrual period, toothache, backache, osteoarthritis, or cold/flu aches, and pain. Furthermore, it is an effective antipyretic used to reduce fever. The growing burden of the indicative conditions and rising demand for OTC products are driving the growth of the market during the forecast period. Moreover, as the older population is more prone to osteoarthritis, toothache and other indicative diseases, the market is expected to witness growth during the forecast period.

Full report of Pain and Fever Relief Drugs Market available @ https://www.omrglobal.com/industry-reports/pain-and-fever-relief-drugs-market

Recent Developments

In March 2020, Johnson & Johnson announced that it will be ramping up production of its flagship product Tylenol which is an over-the-counter pain killer.
In February 2020, GlaxoSmithKline got approval from the FDA for Advil Dual Action, with Acetaminophen as an over-the-counter (OTC) product for pain relief.

Market Coverage

Segment Covered- 
By Drugs
By Distribution Channel
Regions covered-
North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape: AstraZeneca plc, AbbVie Inc., and B. Braun Melsungen AG, among others.

Key questions addressed by the report

What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?

o             Deviation from the pre-COVID-19 forecast

o             Most affected region and segment

Who is the leader in the market?
How are players addressing challenges to sustain growth?
Where is the investment opportunity?

Global Pain and Fever Relief Drugs Market Report by Segment

By Drugs

Aspirin
Diclofenic Acid
Ibuprofen
Aspirin
Paracetamol
Naproxen
Metamizole Sodium

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.




For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/pain-and-fever-relief-drugs-market







Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.